指南与共识呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症医学会成人急性呼吸窘迫综合征神经肌肉阻滞剂使用指南

Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome.
指南 / 共识 · Crit Care Med · 2026-03-03
一句话结论重症医学会指南条件性推荐:PaO2/FiO2低于150的成人ARDS患者使用神经肌肉阻滞剂,其余情形因证据不足未作推荐。

该指南由美国重症医学会(American College of Critical Care Medicine)理事会组建21人多学科专家组,按GRADE方法制定,针对成人ARDS患者神经肌肉阻滞剂(NMBA)使用提出5个PICO问题并做系统评价。最终产生2条条件性推荐,其中一条为PaO2/FiO2低于150的成人ARDS患者使用NMBA;对可滴定与固定剂量给药、用药前或用药中基于监测评估镇静镇痛深度、以及俯卧位患者使用NMBA这3个问题,因危重症患者总体证据缺乏及患者安全与经验考虑,支持与反对双方意见均衡,未形成方向性推荐。指南强调机构条件与患者个体因素须参与决策。

要点

  • 条件性推荐:PaO2/FiO2低于150的成人ARDS患者使用神经肌肉阻滞剂(NMBA)。
  • 可滴定与固定剂量NMBA给药之间,因总体证据缺乏,支持与反对意见均衡,未作方向性推荐。
  • 用药前或用药中基于监测评估镇静镇痛深度这一策略,同样因证据缺乏未形成方向性推荐。
  • 俯卧位患者使用NMBA,因危重症患者证据缺乏及患者安全与经验考虑,未作方向性推荐。
  • 指南强调机构条件与患者个体因素必须参与NMBA决策过程。

适用人群与场景

  • 重症成人急性呼吸窘迫综合征(ARDS)患者。

诊断标准与关键阈值

  • PaO2/FiO2低于150作为条件性推荐使用NMBA的氧合阈值。

处置流程与药物剂量

  • 对PaO2/FiO2低于150的成人ARDS患者使用神经肌肉阻滞剂(NMBA)(条件性推荐)。

研究设计与关键结果

  • 美国重症医学会理事会组建21人多学科专家组,含2名GRADE方法学专家,严格遵循利益冲突政策,识别并构建5个PICO问题,逐题系统评价、统计分析并以GRADE评估证据确定性,用GRADE证据到决策框架形成推荐。
  • 共产生2条条件性推荐,其中一条为PaO2/FiO2低于150的成人ARDS患者使用NMBA。
  • 可滴定与固定剂量NMBA给药、用药前或用药中基于监测评估镇静镇痛深度、俯卧位患者使用NMBA这3个问题,因危重症患者总体证据缺乏及患者安全与经验考虑,支持与反对意见均衡,未形成方向性推荐。

证据类型、等级与局限

  • 证据类型:指南(美国重症医学会,GRADE方法)。
  • 推荐强度:2条为条件性推荐。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对PaO2/FiO2低于150的成人ARDS患者,可依据该条件性推荐使用NMBA。
  • 可滴定与固定剂量给药、基于监测评估镇静镇痛深度、俯卧位患者使用NMBA这3种情形,指南未给出方向性推荐,决策需结合机构条件与患者个体因素。

指南或共识出处

  • Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome(重症医学会成人急性呼吸窘迫综合征神经肌肉阻滞剂使用指南),美国重症医学会(American College of Critical Care Medicine),发表于Critical Care Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: Neuromuscular blocking agents (NMBAs) show potential benefits on mortality and other complications of acute respiratory distress syndrome (ARDS) in adult patients. Evidence-based decisions and processes ensure appropriate use of neuromuscular blockade in adult patients with ARDS.

OBJECTIVES: The objective of these guidelines was to develop evidence-based recommendations for the administration of NMBAs in critically ill adult patients with ARDS.

DESIGN: The American College of Critical Care Medicine Board convened a 21-member multidisciplinary panel of experts in critical care medicine, nursing, respiratory therapy, pharmacology, surgery, neurology, and anesthesiology. The panel included two expert methodologists specialized in developing evidence-based recommendations in alignment with the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. Conflict-of-interest policies were strictly followed during all phases of guidelines development including task force selection and voting.

METHODS: The panel members identified and formulated five Population, Intervention, Comparison, and Outcome questions. We conducted a systematic review for each question to identify the best available evidence, statistically analyzed the evidence, and assessed the certainty of the evidence using the GRADE methodology. We used the GRADE evidence-to-decision framework to formulate the recommendations.

RESULTS: The panel generated two conditional recommendations. One recommendation is to use NMBAs in adults with ARDS with Pao2/Fio2 less than 150. For the other recommendations, there was equipoise in the recommendation for and against using titratable vs. fixed-dose NMBA dosing, a monitoring-based strategy for assessing depth of sedation and analgesia in adults with ARDS before initiating or while receiving neuromuscular blockade, and administration of NMBAs for patients who are proned, due to overall lack of evidence in critically ill patients and due to considerations of patient safety and experience concerns.

CONCLUSIONS: These guidelines provide additional perspectives on the use of NMBA in patients with ARDS, recognizing that institutional and patient-specific considerations must help to guide the decision-making process.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Erstad BL, Cobas MA, Qadir N, et al. Society of Critical Care Medicine Guidelines for the Administration of Neuromuscular Blockade in Adults With Acute Respiratory Distress Syndrome. Crit Care Med. 2026. PMID: 41773929. doi:10.1097/CCM.0000000000007002

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。